World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Links
Vaccines that took 40 years to develop- vaccines for malaria and coronavirus
10/17/2021
In a world of short run startups it is important to remember that our lives truly depend on the work done by scientists over decades. The stories of the scientists who developed the vaccine for malaria and the vaccine for mRNA technologies embedded in Pfizer vaccine.
Linked Articles
The Vaccine That Took 40 Years to Make - The Journal. - WSJ Podcasts
WSJ 10/17/2021
Their coronavirus vaccine candidate has made them billionaires. This modest German Turkish couple doesn’t own a car.Washington Post 10/17/2021
Abbott Lab's medical products company and its focus on emerging markets in China and India
10/20/2011
Abbott see the huge potential for infant nutrition and other businesses related to medical products as millons of people join the middle class in China, India, Vietnam and other emerging markets. Nestle is pursuing a similar idea with its acquisition of Pfizer's infant nutrition business which has a large presence in China. With its strong brand name presence, marketing and distribution, and the growing need for better nutrition in these countries Nestle sees huge potential for growth.
Linked Articles
Abbott to Split Into Two Companies
Wall Street Journal 10/20/2011
Abbott Looks to Consumer for GrowthWall Street Journal 05/03/2012
Pfizer and Merck organize R&D using international innovation hubs- 2011-2015
05/02/2011
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
The different approaches of Pfizer and Novartis for new drug research and development in 2009-2015
06/11/2009
Working with smaller R&D budgets and focussing the research on a few areas, collaboration with universities, and other ways to get more out of the R&D dollar.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Novartis: Radically Remaking Its Drug BusinessBusinessWeek 06/11/2009
Aggressive television advertising by Pfizer and Glaxo Smithkline
10/25/2006
Linked Articles
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10/25/2006
Glaxo to Pare Ads on U.S. TelevisionWall Street Journal 01/09/2009
Pfizer BioNTech Vaccine - the history of two Turkish born immigrant scientists in Germany and how it happened
12/02/2020
Linked Articles
How a Couple’s Quest to Cure Cancer Led to the West’s First Covid-19 Vaccine
WSJ 12/02/2020
Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s EndNYTimes.com 07/22/2020
Pfizer's focus on its core pharmaceutical business in 2011-2015
05/02/2011
Rockoff's interview with Pfizer CEO, Ian Read, in which Read describes his strategy of focussing on new drug development and locating closer to hubs with large universities and research centers such as La Jolla, Cambridge, Massachusetts, and Cambridge, England. Pfizer sold its infant nutrition business to Nestle as part of this plan.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Research and Development (R&D) approaches of pharmaceutical companies Pfizer and Glaxo with smaller budgets and smaller units
07/01/2010
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Glaxo Tries Biotech Model to Spur Drug InnovationsWall Street Journal 07/01/2010
Vaccine Maker Pfizer and the National Childhood Vaccine Injury Compensation Program.
01/26/2009
The limits to litigation risk for vaccines is one reason for the attractiveness and growing investment in the vaccines development. Its also what Pfizer hopes to develop with the Wyeth acquisition for $68 billion.
Linked Articles
Wall Street Journal 02/23/2009
Pfizer Agrees to Pay $68 Billion for Rival WyethNew York Times 01/26/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us